Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites
- PMID: 119352
- DOI: 10.3109/00498257909042327
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites
Abstract
1. The anti-inflammatory agent diclofenac sodium (o-[(2,6-dichlorophenyl)amino]phenylacetic acid sodium salt) is extensively metabolized by rat, dog, baboon and man. The main metabolites were isolated from the urine of all species and from the bile of rat and dog and identified by spectroscopy. 2. Metabolism involves direct conjugation of the unchanged drug, or oxidation of the aromatic rings usually followed by conjugation. Sites of oxidation are either position 3' or 4' of the dichlorophenyl ring or, alternatively, position 5 of the phenyl ring attached to the acetic acid moiety. 3. In the urine of rat, baboon and man conjugates of the hydroxylated metabolites predominate, but the major metabolite in dog urine is the taurine conjugate of unchanged diclofenac. 4. In the bile of rat and dog, the main metabolite is the ester glucuroniade of unchanged diclofenac.
Similar articles
-
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile.Xenobiotica. 1979 Oct;9(10):611-21. doi: 10.3109/00498257909042328. Xenobiotica. 1979. PMID: 119353
-
Disposition and enterohepatic circulation of diclofenac in dogs.Arzneimittelforschung. 1980;30(10):1650-3. Arzneimittelforschung. 1980. PMID: 7192104
-
The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man.Rheumatol Rehabil. 1979;Suppl 2:22-37. Rheumatol Rehabil. 1979. PMID: 119296 No abstract available.
-
Comparative metabolism of fenclorac in rat, dog, monkey, and man.Drug Metab Dispos. 1977 Mar-Apr;5(2):122-31. Drug Metab Dispos. 1977. PMID: 15804
-
Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren.Scand J Rheumatol Suppl. 1978;(22):17-29. doi: 10.3109/03009747809097212. Scand J Rheumatol Suppl. 1978. PMID: 98834 No abstract available.
Cited by
-
Setup of human liver-chips integrating 3D models, microwells and a standardized microfluidic platform as proof-of-concept study to support drug evaluation.Biomater Biosyst. 2022 May 30;7:100054. doi: 10.1016/j.bbiosy.2022.100054. eCollection 2022 Aug. Biomater Biosyst. 2022. PMID: 36824483 Free PMC article.
-
Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.Clin Pharmacokinet. 1997 Sep;33(3):184-213. doi: 10.2165/00003088-199733030-00003. Clin Pharmacokinet. 1997. PMID: 9314611 Review.
-
Development of Novel Diclofenac Analogs Designed to Avoid Metabolic Activation and Hepatocyte Toxicity.ACS Omega. 2020 Dec 8;5(50):32608-32616. doi: 10.1021/acsomega.0c04942. eCollection 2020 Dec 22. ACS Omega. 2020. PMID: 33376898 Free PMC article.
-
Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oral dose in rats.BMC Pharmacol. 2009 Mar 16;9:5. doi: 10.1186/1471-2210-9-5. BMC Pharmacol. 2009. PMID: 19291310 Free PMC article.
-
Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans.Br J Clin Pharmacol. 1999 Jun;47(6):625-35. doi: 10.1046/j.1365-2125.1999.00935.x. Br J Clin Pharmacol. 1999. PMID: 10383540 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources